
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES262
Overall, the study did not find significant differences in the use of any antihypertensive agent
(specifically renin-angiotensin system inhibitors (RAS-inhibitors)) for patients with a GFR
<60 ml/min 1.73 m2 and normo-, micro- or macroalbuminuria. Level 2+

[@MacIsaac_2004]

